Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo

Journal of Immunology

Volumn 160, Issue 4, 1998, Pages 1841-1849

  Fernandez Sesma, Ana ^a   Peluso, Richard W ^b   Bai, Xu ^a   Schulman, Jerome L ^a   Levy, David E ^c   Moran, Thomas M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Quality Biotech   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; CD8 ANTIGEN; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; STAPHYLOCOCCUS ENTEROTOXIN B; STAT1 PROTEIN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE ACTIVATION; VESICULAR STOMATITIS VIRUS; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIVIRAL AGENTS; CELLS, CULTURED; CRICETINAE; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENTEROTOXINS; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RHABDOVIRIDAE INFECTIONS; SPECIES SPECIFICITY; STAPHYLOCOCCUS AUREUS; STOMATITIS; SUPERANTIGENS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VESICULAR STOMATITIS-INDIANA VIRUS; VIRUS REPLICATION;

EID: 0032519435     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Zinkernagel, R. M. 1996. Immunology taught by viruses. Science 271:173.
2. + cytotoxic T lymphocytes. Eur. J. Immunol 26:2595.
3. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 84:443.
4. Fanger, M. W., P. M. Morganelli, and P. M. Guyre. 1992. Bispecific antibodies. Crit. Rev. Immunol. 12:101.
5. Fernandez-Sesma, A., J. L. Schulman, and T. M. Moran. 1996. A bispecific antibody recognizing influenza A virus M2 protein redirects effector cells to inhibit virus replication in vitro. J. Virol. 70:4800.
6. Moran, T. M., E. Toy, Y. Kuzu, H. Kuzu, H. Isobe, and J. L. Schulman. 1995. Staphylococcal enterotoxin B-activated T cells can be redirected to inhibit multicycle virus replication. J. Immunol. 155:759.
7. Moran, T. M., O. Usuba, H. Kuzu, Y. Kuzu, J. Schulman, and C. A. Bona. 1991. Inhibition of multicycle influenza virus replication by hybrid antibody-directed cytotoxic T lymphocyte lysis. J. Immunol. 146:321.
8. Rodriguez-Boulan, E. 1983. Polarized assembly of enveloped viruses from cultured epithelial cells. Methods Enzymol. 98:486.
9. Wagner, R. R., and J. Rose. 1996. Rhabdoviridae: the viruses and their replication. In Fields Virology, 3rd Ed. Vol. 1. B. N. Fields, D. M. Knipe, and P. H. Howley, eds. Lippincott-Raven Publishers, Philadelphia, p. 1121.
10. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent end points. Am. J. Hyg. 27:493.
11. Staerz, U. D., and M. J. Bevan. 1986. Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T cell activity. Proc. Natl. Acad. Sci. USA 83:1453.
12. Ozmen, L., M. Aguet, G. Trinchieri, and G. Garotta. 1995. The in vivo antiviral activity of interleukin-12 is mediated by gamma interferon. J. Virol. 69:8147.
13. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25.
14. + T cells. J. Exp. Med. 174:875.
15. + T cells promote the clearance of influenza virus from major histocompatibility complex class II -/-respiratory epithelium. J. Virol. 70:1288.
16. Bender, B. S., T. Croghan, L. Zhang, and P. A. Small. Jr. 1992. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J. Exp. Med. 175:1143.
17. + T cells. J. Immunol. 149:1319.
18. Scherle, P. A., G. Palladino, and W. Gerhard. 1992. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J. Immunol. 148:212.
19. + T-cell deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc. Natl. Acad. Sci. USA 89:6070.
20. Bi, Z., P. Quandt, T. Komatsu, M. Barna, and C. S. Reiss. 1995. IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J. Immunol. 155:5684.
21. Demanet, C., J. Brissnick, M. Van Mechelen, O. Leo, and K. Thielemans. 1991. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype × anti-CD3). J. Immunol. 147:1091.
22. Demanet, C., J. Brissnick, O. Leo, M. Moser, and K. Thielemans. 1994. Role of T-cell subsets in the bispecific antibody (anti-idiotype × anti-CD3) treatment of the BCL1 lymphoma. Cancer Res. 54:2973.
23. Renno, T., M. Hahne, J. Tschopp, and H. R. MacDonald. 1996. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J. Exp. Med. 183:431.
24. Kägi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Bürki, R. M. Zinkernagel, and H. Hengartner. 1995. The roles of perform- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:43256.
25. Howell, A. L., P. M. Guyre, K-S. You, and M. W. Fanger. 1994. Targeting HIV-1 to FcγR on human phagocytes via bispecific antibodies reduces infectivity of HIV-1 to T cells. J. Leukocyte Biol. 55:385.
26. + effectors to kill HIV-1-infected cells. J. Immunol. 153:4268.
27. Gilbert, M. J., S. R. Riddell, B. Plachter, and P. D. Greenberg. 1996. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature 383:720.
28. Koup, R. A. 1994. Virus escape from CTL recognition J. Exp. Med. 180:779.
29. Kontermann, R. E., M. G. Wing, and G. Winter. 1997. Complement recruitment using bispecific antibodies. Nat. Biotechnol. 15:629.
30. Deo, Y. M., R. F. Graziano, R. Repp, and J. G. Van de Winkel. 1997. Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies. Immunol. Today 18:127.
31. Holliger, P., M. Wing, J. D. Pound, H. Bohlen, and G. Winter. 1997. Retargeting serum immunoglobulin with bispecific diabodies. Nat. Biotechnol. 15:632.
32. Moreno, M. B., J. A. Titus, M. S. Cole, J. Y. Tso, N. Le, C. H. Paik, T. Bakacs, C. M. Zacharchuk, D. M. Segal, and J. R. Wunderlich. 1995. Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo. Cancer Immunol. Immunother. 40:182.
33. Penna, C., P. A. Dean, and H. Nelson. 1994. Antitumor × anti-CD3 bifunctional antibodies redirect T cells activated in vivo with staphylococcal enterotoxin B to neutralize pulmonary metastases. Cancer Res. 54:2738.
34. Robert, B., J. P. Mach, J. C. Mani, M. Ychou, S. Folli, J. C. Artus, and A. Pelegrin. 1996. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha. Cancer Res. 56:4758.
35. Sahin, U., S. Kraft-Bauer, S. Ohnesorge, M. Pfreundschuh, and C. Renner. 1996. Interleukin-12 increases bispecific antibody-mediated natural killer cell cytotoxicity against human tumors. Cancer Immunol. Immunother. 42:9.
36. Weiner, L. M., J. I. Clark, M. Davey, W. S. Li, I. Garcia-de Palazzo, D. B. Ring, and R. K. Alpaugh. 1995. Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-ERB-2 and Fc gamma RIII. Cancer Res. 55:4586.
37. Mabondzo, A., F. Boussin, H. Raoul, R. Le Naour, G. Gras, B. Vaslin, J. Bartholeyns, J. L. Romet-Lemonne, and D. Dormont. 1994. Antibody-dependent cellular cytotoxicity and neutralization of human immunodeficiency virus type 1 by high affinity cross-linking of gp41 to human macrophage Fc IgG receptor using bispecific antibody. J. Gen. Virol. 75:1451.
38. Mabondzo, A., R. Le Naour, R. Le Grand, B. Vaslin, O. Benveniste, A. Cheret, H. Raoul, J. L. Romet-Lemonne, and D. Dormont. 1995. Functional consequences of macrophage infection by human immunodeficiency virus: bispecific antibody-targeting of HIV-1-infected cells to Fc gamma RI expressing effector cells. J. Hematother. 4:579.
39. Wickham, T. J., D. M. Segal, P. W. Roelvink, M. E. Carrion, A. Lizonova, G. M. Lee, and I. Kovesdi. 1996. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70:6831.